Harry H. Yoon, MD, MHS, discusses tislelizumab and platinum-containing chemotherapy in unresectable or metastatic esophageal squamous cell carcinoma whose tumors express PD-L1 at a level of 1 or ...

PRT3789 has demonstrated clinical proof-of-concept that selectively degrading SMARCA2 is generally safe and has monotherapy anti-tumor activity ...

Whalen, PhD, poses a new explanation for how cancer-fighting drugs attack and destroy BRCA1 and BRCA2 tumor cells. Published in Nature Cancer, their work illustrates how a small DNA nick-a break ...

Teddi Mellencamp has revealed doctors have discovered five more tumors in her body just weeks after she underwent emergency brain cancer surgery. The former Real Housewives of Beverly Hills ...

Teddi Mellencamp has shared a heartbreaking update on her cancer battle, as doctors have discovered more tumors in her body. In February, the 43-year-old shared that she had been diagnosed with ...

Esophageal squamous cell carcinoma accounts for approximately 90% of all esophageal cancer cases. Projections estimate that by 2040, there will be approximately 957,000 new cases of esophageal cancer ...

In participants with a PD-L1 Tumor Area Positivity of at least ... Tevimbra is also indicated for esophageal cancer as monotherapy in adults with unresectable or metastatic ESCC after prior ...

New indication for Tevimbra in combination with platinum-containing chemotherapy as a first-line treatment addresses an unmet ...

BeiGene's Tevimbra wins FDA approval for first-line metastatic ESCC treatment, showing significant survival benefits in PD-L1-positive patients.

BeiGene (NASDAQ:ONC) announced Tuesday that the U.S. Food and Drug Administration (FDA) approved its anti-tumor agent Tevimbra as a first-line therapy for certain patients with esophageal cancer as ...

During a recent appearance on "The Kelly Clarkson Show," the 57-year-old actress recalled being diagnosed with a noncancerous brain tumor in 2015 and shared how the experience changed her approach ...

Osamu Nishimura, a prominent Japanese wrestler, has died at 53 after battling esophageal cancer. Despite his late-stage diagnosis, he continued wrestl ...